Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ATYRATYR
Showing 7 of 10 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ATYR PHARMA INC

GOLDMAN SACHS GROUP INC holds 641,208 shares of ATYR (ATYR PHARMA INC), worth $382,672 as of 2026-Q2. The position was increased (+126.4% shares).

Current Value

$382,672

Current Shares

641,208

Total Value Change

-$565,120

Total Shares Change

+379,387

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
641,208
+126.4%
$382,6720.0%$0.60
26
2026-Q1
Decreased
283,236
-18.0%
$220,9240.0%$0.78
0
2025-Q4
Decreased
345,587
-49.8%
$270,6290.0%$0.78
0
2025-Q3
Increased
688,165
+1797.1%
$496,4430.0%$0.72
39
2025-Q2
Decreased
36,275
-90.5%
$183,9140.0%$5.07
0
2025-Q1
Increased
382,317
+46.0%
$1.2M0.0%$3.02
34
2024-Q4
New
261,821
-
$947,7920.0%$3.62
35

Other major holders of ATYR: FEDERATED HERMES, INC., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used